The annual American Association of Cancer Research meeting (AACR) was held April 18–22 in Philadelphia, Pennsylvania. Attendance for the conference was 19,300, up about 4% from last year (see IBO 4/30/14). The number of companies exhibiting totaled 438. A notable trend in the exhibit hall was the number of CRISPR/Cas9 products and services available from […]
With the completed acquisition of Life Technologies (see IBO 2/15/14) in 2014, Thermo Fisher Scientific further solidified its number one position among IBO’s list of the top 30 analytical and life science instrument, aftermarket and lab product companies. All sales and sales growth figures in this article are based on IBO’s calculations of companies’ revenues […]
Company Announcements In February, LifeMap Sciences announced a commercial partnership agreement with Toldot Genomics involving their respective GeneCards Suite and next-generation sequencing (NGS) data-analysis capabilities. BD Life Sciences and Cellular Research announced the joint promotion of their respective BD FACS single-cell sorter and Precise assays for single-cell sequencing. In February, Illumina received regulatory approval from […]
Company Announcements In January, Agilent Technologies named Alacris Theranostics as an Agilent Certified Service Provider for target enrichment. PreAnalytiX, NuGEN Technologies and RUCDR Infinite Biologics partnered to validate an end-to-end workflow for the reproducible collection and processing of whole blood for RNA-Seq in clinical studies. In February, Japan’s Quantum Biosystems announced that it raised ¥2.4 […]
This month, the Association for Molecular Pathology (AMP) released the results of its cost analysis and health economic–evaluation models for a number of genomic sequencing–procedure (GSP) CPT codes. The organization also released a template tool for molecular-diagnostic labs to determine the costs of their next-generation sequencing (NGS) assays for GSPs. The AMP performed the analysis […]
Washington, DC 2/27/15; Billerica, MA 3/2/15—RainDance Technologies has filed with the SEC for a proposed IPO of its common stock on the NASDAQ Stock Market under the symbol “RAIN.” The company develops, manufactures and sells systems based on its digital droplet technology as well as consumables and assays for the detection and analysis of complex […]
Epigenetics, the study of heritable phenotypic changes that are not attributable to changes in DNA sequence, is a rapidly advancing field that is increasingly providing insight into a range of genetic phenomena. Epigenetic changes regulate gene expression independent of genetic sequence. Questions addressed by the field include cell differentiation, tumorogenesis and expression of traits inherited […]
Company Announcements Genomics, a developer of an analytical platform for genomic-sequence data analysis and interpretation, completed a £10.3 million ($16.1 million) fundraising round in November 2014. In December 2014, Tute Genomics, a provider of a cloud-based genome analytics platform, raised $2.3 million in Series A1 funding. Kapa Biosystems expanded its partnership with Roche NimbleGen to […]
The annual JP Morgan Healthcare conference held in early January is a major investor conference for health care companies, including instrument and lab-product companies. Several such companies presented business and strategy updates at the conference, highlighting their successes of the past year and plans for 2015. The information in this article is based on online […]
The life science (LS) market consists of 14 distinct technology categories and is the largest of all analytical-instrument markets, including aftermarket and service revenues. In this year’s forecast issue, the LS category also includes capillary electrophoresis, which was previously counted as part of the separations market. In 2014, the LS market increased 5.9% to $11.8 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
